SZOT MATTHEW K (Chief Financial Officer) sold 9.93K shares of CADRENAL THERAPEUTICS, INC. on the open market
Open‑market sale worth $69.2K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/31/2025ACC: 0001213900-25-127110
Officer· Chief Financial Officer
Since Jan 2023
-9.93K
Net shares
Net seller
$69.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.93K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.93K
Price / share
$6.97
Trade value
$69.23K
% of position
New position
12/29/2025
9.93K→0.00
Total
Net shares
−9.93K
Net value
-$69.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/29/2025 | S · Sale | −9.93K | $6.97 | $69.23K | New position | 9.93K | 0.00 |
| Total | −9.93K | -$69.23K | ||||||
Derivative Transactions0
No derivative transactions reported